
==== Front
Qatar Med J
Qatar Med J
Qatar Medical Journal
0253-8253
2227-0426
HBKU Press Qatar

qmj.2024.47
10.5339/qmj.2024.47
Case Report
Pediatric puzzle: Large ovarian dermoid cyst and markedly elevated CA 19-9 in an 8-year-old
Pediatric puzzle: Large ovarian dermoid cyst and markedly elevated CA 19-9 in an 8-year-old
Abdelmoaty et al.
Abdelmoaty Muhamed Ahmed 1 * †
Taha Wael Soliman 1 †
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt *Email: MuhamedAhmed.216@azhar.edu.eg

*Email: MuhamedAhmed.216@azhar.edu.eg
†ORCID: Muhamed Ahmed Abdelmoaty, orcid.org/0000-0003-4206-2157; Wael Soliman Taha, orcid.org/0009-0001-7634-2408

2024
16 9 2024
2024 3 4723 2 2023
23 6 2024
© 2024 Abdelmoaty, Taha, Licensee HBKU Press.
2024
HBKU Press.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Background

Mature cystic teratomas, also known as dermoid cysts, are the most prevalent form of ovarian germ cell tumors. While they typically manifest in women of reproductive age, they can also occur in pediatric patients. These tumors are generally benign and comprise a diverse array of tissue types. However, large lesions, particularly those exceeding 10 cm in diameter, are infrequent and can present diagnostic and therapeutic challenges. Notably, elevated tumor markers, such as cancer antigen 19-9 (CA 19-9), are not commonly associated with mature cystic teratomas, rendering this case particularly unusual.

Case presentation

The clinical case involved an 8-year-old female patient who presented with an exceptionally large ovarian teratoma, measuring 13 × 12 cm. While the prepubertal presentation of such tumors is not uncommon, the remarkable size of the lesion was an extraordinary occurrence. Preoperative evaluation revealed markedly elevated levels of CA 19-9, a tumor marker, at 297 U/mL—an atypical finding for mature cystic teratomas. Imaging studies identified a complex cystic adnexal mass, indicative of a teratoma. Consequently, a laparotomy was performed, revealing an intact, benign lesion that was successfully resected via cystectomy, with preservation of the ovary. Histopathological examination confirmed the diagnosis of a mature cystic teratoma, without any evidence of malignant transformation. Notably, following the surgical intervention, the elevated CA 19-9 levels normalized, suggesting a potential association between the teratoma and the abnormal tumor marker levels.

Discussion

This report delineates the surgical management and clinical course of an exceptionally large ovarian teratoma in a pediatric patient with abnormal preoperative tumor markers. Despite atypical features, the excellent prognosis following fertility-sparing resection underscores the significance of conservative treatment in young females.

Conclusion

This case highlights the occurrence of a large mature cystic teratoma with elevated CA-19-9 in a pediatric patient with no complications such as torsion, rupture, or malignancy. The elevation in CA-19-9 likely relates directly to the teratoma itself. A conservative, fertility-sparing surgical approach proved effective, emphasizing the importance of careful preoperative evaluation and management in similar cases.

Keywords:

Dermoid cyst
ovarian
CA-19-9 antigen
teratoma
cystic
ultrasonography
==== Body
pmc1. Introduction

Mature cystic teratomas, known as dermoid cysts, are germ cell tumors originating from ovarian tissue that contain developmentally mature tissue from all three germ cell layers.1 They are the most frequent subtype of ovarian germ cell tumors, accounting for approximately 11% of all ovarian neoplasms and 69% of all germ cell tumors. The reported incidence of mature cystic teratomas varies widely, ranging from approximately 1.2 to 14.2 cases per 100,000 individuals annually.2

The typical presentation of mature cystic teratomas is in patients during their reproductive years, with reported age ranges from 13 to 76 and a median age in the mid-30s.3 While most mature cystic teratomas are benign, the literature estimates a 0.5–3% frequency of malignant transformation, which appears to be greater in older women.4 Squamous cell carcinoma is the most common histologic type among individuals undergoing malignant transformation.5

The clinical presentation of ovarian dermoid cysts is highly variable. Approximately 20% of cases are asymptomatic, often discovered incidentally during imaging studies or surgical procedures.6,7 Symptomatic individuals may present with chronic pelvic pain, increased pelvic pressure, or acute abdominal pain resulting from complications such as ovarian torsion or rupture.7-9

The most commonly used imaging approach for confirming ovarian dermoid cysts is ultrasound (US), which is accurate enough to provide a diagnosis that can be verified by postoperative histology.10 The presence of a dermoid plug or Rokitansky nodule on imaging is regarded as strong radiographic evidence supporting a teratoma diagnosis.11 Dermoid cysts can be diagnosed with computed tomography or Magnetic Resonance Imaging (MRI), both of which are more sensitive to fat than US.12

On gross examination, ovarian dermoid cysts typically appear as unilocular cysts containing Rokitansky nodules, which include hair, teeth, and other tissues (Figure 3).13 Histologically, these tumors are characterized by well-differentiated tissues originating from all three germ layers. Ectodermal tissues and sebaceous material are almost universally present. The cyst cavity is filled with sebaceous material, and the lining is composed of squamous epithelium. Mesodermal tissues, such as fat, bone, cartilage, and muscle, are present in over 90% of cases, while endodermal tissues are encountered less frequently.2

Immunohistochemistry (IHC) is a highly sensitive technique used to identify tissue antigens with specific antibodies visible under a microscope. It is crucial in various research and pathological applications, including histogenetic diagnosis, neoplasia subtyping, identifying primary sites of malignant tumors, assessing prognostic factors, and differentiating between benign and malignant cell proliferations.14 IHC is often employed in cases of malignant transformation in mature cystic teratomas to detect specific antigens and assist in management.15

Cancer antigen 19-9 (CA 19-9), also known as sialylated Lewis (a) antigen, is a tumor marker found in cell membranes that undergoes changes throughout malignant transformation. CA 19-9 is most typically high in pancreatic, biliary, colonic, esophageal, and hepatic cancers, although it can also be elevated in some benign diseases.16 CA 19-9 has recently been found as a possible diagnostic marker for ovarian mature cystic teratomas, despite the fact that it is not typically increased in most instances.17 Serum CA 19-9 levels in mature cystic teratomas are infrequently documented in the literature,18 especially in younger individuals, and are generally linked with complications such as torsion.19

To the best of the authors’ knowledge, this case involves a prepubertal female with an ovarian mature cystic teratoma who had the youngest age at presentation and a high CA 19-9 level. Institutional protocol was followed, and formal parental approval was obtained before publishing this case report with images.

2. Case Presentation

An 8-year-old female presented to our clinic with a history of chronic abdominal pain and distension. Physical examination revealed a mobile pelvic-abdominal mass extending beyond the umbilicus. Ultrasonography demonstrated a 13 × 12 cm complex cystic lesion in the pelvis with a peripheral solid component and preserved peripheral ovarian blood flow on Doppler. MRI confirmed these findings, with the cystic portion displaying low T1 and high T2/STIR signal intensity, while the solid area showed high T1 and low T2/STIR signal with foci of susceptibility artifact concerning for calcifications.

Laboratory evaluation revealed normal levels of beta-human chorionic gonadotropin, alpha-fetoprotein, and carcinoembryonic antigen at <2, 1.85, and 1.88 ng/mL, respectively. Cancer antigen 125 was normal at 12.2 U/mL. However, CA 19-9 was significantly elevated at 297 U/mL (normal range 2.5–33.5 U/mL). Gastrointestinal malignancies were ruled out on imaging.

The patient underwent surgical excision of the cyst 2 weeks after initial presentation to our clinic via a Pfannenstiel skin incision and longitudinal rectus fascia opening to facilitate removal (Figure 1). Cystectomy was performed without cyst wall rupture, with ovarian preservation after cortical reconstruction (Figure 2). The remaining pelvic organs and peritoneum appeared normal on visual inspection. Histopathological examination confirmed the diagnosis of a benign mature cystic teratoma. The patient was admitted to our department for a total of 12 days, consisting of 7 days prior to the surgery and 5 days post-surgery. The abnormal preoperative CA 19-9 level normalized within 4 weeks postoperatively.

3. Discussion

Mature cystic teratomas (MCTs), commonly known as dermoid cysts, are the most prevalent benign ovarian neoplasms in women of reproductive age and adolescents. These masses account for approximately 70% of benign ovarian masses before menopause and a substantial 20% thereafter.20,21 Histologically, MCTs consist of mature tissues derived from the three germ cell layers: ectoderm, mesoderm, and endoderm (Figure 4). As a result, they contain a wide variety of tissue types, including skin, hair, teeth, fat, muscle, thyroid, and even neural elements. The term “dermoid cyst” specifically refers to MCTs that are predominantly composed of ectodermal derivatives.22 One hypothesis regarding their pathogenesis suggests that MCTs arise from parthenogenic embryogenesis within an ovum, which gives them their remarkable pluripotent capacity.23

Ultrasonography is considered the first-line imaging modality for the evaluation of adnexal masses. On US, mature cystic teratomas classically appear as heterogeneous lesions with hyperechoic foci and acoustic shadowing from calcifications, sebum, and hair. More specific sonographic findings include fat-fluid levels, a Rokitansky nodule, an iceberg sign, a dermoid mesh pattern, and a floating balls sign. Transvaginal US has been shown to have a sensitivity of 57.9% and specificity of 99.7% for detecting ovarian cystic teratomas, comparable accuracy to MRI. The heterogeneity, fat contents, and calcifications produce characteristic ultrasonographic features that aid in the diagnosis of mature cystic teratomas noninvasively.22,24

While most mature cystic teratomas remain benign, approximately 1.5%–2% may undergo malignant transformation. The most common malignancy arising in mature cystic teratomas is squamous cell carcinoma, typically developing from ectodermal elements.25 Interestingly, studies have found that the elevation of tumor markers like CA 125 and CA 19-9 does not correlate with malignant transformation to squamous cell carcinoma in these lesions. Therefore, while CA 125 and CA 19-9 can be elevated in benign mature cystic teratomas, these markers do not appear helpful for indicating malignant degeneration specifically into squamous cell carcinoma. Complete surgical excision and histopathological examination remain essential for assessing malignant features.26

Several retrospective studies have aimed to correlate CA 19-9 levels with specific clinical features of mature cystic teratomas. Some have found associations between higher CA 19-9 levels and larger tumor size, though statistical significance has been inconsistent.27 A positive correlation between CA 19-9, tumor size, and fat content has also been reported.28 However, other studies have failed to demonstrate a clear relationship between CA 19-9 elevation and meaningful parameters.29

Potential explanations for CA 19-9 elevation include leakage from a weakened cyst wall into circulation, especially in larger lesions.18 CA 19-9 rise may also relate to ovarian torsion and the degree of necrosis, possibly due to inflammatory changes from the ischemic reaction.30 Overall, CA 19-9 appears to be a sensitive marker for ovarian torsion and necrosis extent in mature cystic teratomas, for which prompt detection is clinically important.19 However, the precise etiology and clinical utility of CA 19-9 elevation require further elucidation.

In our prepubertal patient, the mature cystic teratoma was remarkably large at 13 × 11 cm (as measured postoperatively), and the CA 19-9 level was moderately elevated at 297 U/mL, though other tumor markers remained within normal limits. On laparotomy, the mass appeared grossly benign with a smooth surface and no adhesions or invasion into surrounding pelvic structures. Despite the large size, there was no evidence of torsion or rupture; however, the cyst wall was very thin and fragile with visibility of interior hair contents. Given the lack of malignant features and the patient’s young age, cystectomy alone with ovarian preservation was performed. Had malignant transformation been suspected intraoperatively, oophorectomy may have been warranted. Long-term follow-up for recurrence risk is planned, though the prognosis for this young patient is excellent after full resection of this benign lesion.

4. Conclusion

This case highlights an exceptionally large mature cystic teratoma in a pediatric patient, notable for an abnormally elevated CA 19-9 level. The tumor’s significant size and the unusual elevation of the tumor marker underscore the rarity of this presentation. Despite these atypical features, there were no complications such as torsion, rupture, or malignancy, suggesting a direct but unclear link between the teratoma and the rise in CA 19-9. A conservative, fertility-preserving surgical approach was judiciously chosen following a comprehensive preoperative evaluation. This report underscores the diverse manifestations of ovarian teratomas and reinforces the importance of meticulous clinical assessment and tailored management, particularly in pediatric patients.

Conflict of Interest Statement

The authors declare that they have no competing interests.

Ethics Approval and Consent to Participate

This case report involves a single patient who was under the care of Al-Hussein University Hospital, and the study was conducted in accordance with the ethical standards of the institution’s research committee. Written informed consent was obtained from the patient’s parent prior to inclusion in this study. Details that might disclose the identity of the patient have been omitted.

Consent for Publication

Written informed consent was obtained from the patient’s parent for publication of the patient’s clinical details and accompanying images in this case report. A copy of the consent form is available for review by the Editor of this journal.

Availability of Data and Materials

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Authors’ Contributions

Both authors contributed equally to this work, involved in the preoperative assessment, surgical procedure, postoperative evaluation, writing of the initial manuscript, revising the manuscript, and read and approved the final manuscript.

Figure 1. Ovarian cyst before the excision. Note the weak wall of the cyst in some areas.

Figure 2. Reconstruction of the ovary after complete excision of the cyst.

Figure 3. Cut section of the cyst. Not the hair follicles (yellow arrow) and the sebaceous material (green arrow).

Figure 4. Histopathological assessment of the cyst. (A) Cyst wall lined by stratifies squamous epithelium with skin appendages with loose keratin flakes in the lumen. (B) Adipose tissue (yellow arrow), sebaceous glands (green arrow), and hair follicles.
==== Refs
References

1 Chen VW Ruiz B Killeen JL Coté TR Wu XC Correa CN Pathology and classification of ovarian tumors Cancer 2003; 97 (Suppl. 10): 2631-42 10.1002/cncr.11345 12733128
2 Cong L Wang S Yeung SY Lee JHS Chung JPW Chan DYL Mature cystic teratoma: An integrated teview Int J Mol Sci 2023; 24 (7): 6141 10.3390/ijms24076141 37047114
3 x Ayhan A Bukulmez O Genc C Karamursel BS Ayhan A Mature cystic teratomas of the ovary: Case series from one institution over 34 years Eur J Obstet Gynecol Reprod Biol 2000; 88: 153-7 10.1016/s0301-2115(99)00141-4 10690674
4 Kido A Togashi K Konishi I Kataoka ML Koyama T Ueda H Dermoid cysts of the ovary with malignant transformation: MR appearance Am J Roentgenol 1999; 172: 445-9 10.2214/ajr.172.2.9930800 9930800
5 Gadducci A Pistolesi S Guerrieri ME Cosio S Carbone FG Naccarato AG Malignant transformation in mature cystic teratomas of the ovary: Case reports and review of the literature Anticancer Res 2018; 38: 3669-75 10.21873/anticanres.12644 29848726
6 Ayhan A Bukulmez O Genc C Karamursel BS Ayhan A Mature cystic teratomas of the ovary: Case series from one institution over 34 years Eur J Obstet Gynecol Reprod Biol 2000; 88 (2): 153-7 10.1016/s0301-2115(99)00141-4 10690674
7 Saleh M Bhosale P Menias CO Ramalingam P Jensen C Iyer R Ovarian teratomas: Clinical features, imaging findings and management Abdom Radiol (NY) 2021; 46 (6): 2293-307 10.1007/s00261-020-02873-0 33394097
8 Jha S Goel G Sinha HH Anant M Agarwal M Effects of intraoperatively ruptured Ovarian dermoid cysts J Gynecol Surg 2022; 38: 221-5 10.1089/gyn.2021.0125
9 Tanaka Y Hori H Gorai I Chemical peritonitis caused by an iatrogenic rupture of mature cystic teratoma of the ovary during labor: A report of a case didactic to all the maternity health care workers J Matern Fetal Neonatal Med 2011; 24 (2): 388-90 10.3109/14767058.2010.482626 20459340
10 Tan P Willatt J Lindsell D The ability of ultrasound to detect gynaecological neoplasms and their ultrasound morphological features Australas Radiol 2007; 51: 260-6 10.1111/j.1440-1673.2007.01723.x 17504319
11 Hertzberg BS Kliewer MA Sonography of benign cystic teratoma of the ovary: Pitfalls in diagnosis Am J Roentgenol 1996; 167: 1127-33 10.2214/ajr.167.5.8911163 8911163
12 Kite L Uppal T Ultrasound of ovarian dermoids—Sonographic findings of a dermoid cyst in a 41-year-old woman with an elevated serum hCG Australas J Ultrasound Med 2011; 14: 19-21 10.1002/j.2205-0140.2011.tb00119.x 28191116
13 Friedman AC Pyatt RS Hartman DS Downey EF Jr Olson WB CT of benign cystic teratomas AJR Am J Roentgenol 1982; 138 (4): 659-65 10.2214/ajr.138.4.659 6978028
14 Atallah GA Kampan NC Chew KT Mohd Mokhtar N Zin RR Shafiee MNB Predicting prognosis and platinum resistance in ovarian cancer: Role of immunohistochemistry biomarkers Int J Mol Sci 2023; 24 (3): 1973 10.3390/ijms24031973 36768291
15 Chiang AJ Chen MY Weng CS Lin H Lu CH Wang PH Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A Taiwanese gynecologic oncology group (TGOG) study J Gynecol Oncol 2017; 28 (5): e69 10.3802/jgo.2017.28.e69 28657230
16 Scarà S Bottoni P Scatena R CA 19-9: Biochemical and clinical aspects Adv Exp Med Biol 2015; 867: 247-60 10.1007/978-94-017-7215-0_15 26530370
17 Ustunyurt E Gungor T Iskender C Iskender C Ustunyurt BO Bilge U Erratum to: Tumor markers in mature cystic teratomas of the ovary Arch Gynecol Obstet 2015; 291: 231 10.1007/s00404-014-3501-4 25284628
18 Sampaio J Sarmento-Gonçalves I Barros JM Felix J Tiago-Silva P Mature cystic teratoma of Ovary with abnormally high levels of Ca19-9: A case report Rev Bras Ginecol Obstet 2016; 38 (7): 365-7 10.1055/s-0036-1586161 27434195
19 Ulkumen BA Goker A Pala HG Ordu S Abnormal elevated Ca 19–9 in the dermoid cyst: A sign of the ovarian torsion? Case Rep Obstet Gynecol 2013; 20 (13): 860505 10.1155/2013/860505
20 Mahe E Sur M Squamous lesions of the ovary Arch Pathol Lab Med 2011; 135 (12): 1611-4 10.5858/arpa.2010-0640-RS 22129194
21 Sinha A Ewies AA Ovarian mature cystic teratoma: Challenges of surgical management Obstet Gynecol Int 2016; 2016: 2390178 10.1155/2016/2390178 27110246
22 Sahin H Abdullazade S Sanci M Mature cystic teratoma of the ovary: A cutting edge overview on imaging features Insights Imaging 2017; 8 (2): 227-41 10.1007/s13244-016-0539-9 28105559
23 Multani J Kives S Dermoid cysts in adolescents Curr Opin Obstet Gynecol 2015; 27 (5): 315-9 10.1097/GCO.0000000000000206 26308203
24 Srisajjakul S Prapaisilp P Bangchokdee S Imaging features of unusual lesions and complications associated with ovarian mature cystic teratoma Clin Imaging 2019; 57: 115-23 10.1016/j.clinimag.2019.05.013 31212220
25 Atwi D Kamal M Quinton M Hassell LA Malignant transformation of mature cystic teratoma of the ovary J Obstet Gynaecol Res 2022; 48 (12): 3068-76 10.1111/jog.15409 36053141
26 Yoshioka T Tanaka T Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary J Obstet Gynaecol Res 1998; 24 (2): 83-90 10.1111/j.1447-0756.1998.tb00057.x 9631595
27 Dede M Gungor S Yenen MC Alanbay I Duru NK Haşimi A CA19-9 may have clinical significance in mature cystic teratomas of the ovary Int J Gynecol Cancer 2006; 16 (1): 189-93 10.1111/j.1525-1438.2006.00284.x 16445632
28 Cho HY Kim K Jeon YT Kim YB No JH CA19-9 elevation in ovarian mature cystic teratoma: Discrimination from ovarian cancer - CA19-9 level in teratoma Med Sci Monit 2013; 19: 230-5 10.12659/MSM.883865 23539074
29 Frimer M Seagle BLL Chudnoff S Goldberg GL Shahabi S Role of elevated cancer antigen 19-9 in women with mature cystic teratoma Reprod Sci 2014; 21 (10): 1307-11 10.1177/1933719114525274 24577158
30 Suh DS Moon SH Kim SC Joo JK Park WY Kim KH Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary World J Surg Oncol 2014; 12: 353 10.1186/1477-7819-12-353 25416055
